A Phase 2, Multi-center, Randomized, Double-masked, Placebo (Vehicle)-Controlled Clinical Study With an Open Label Comparator Arm to Assess the Efficacy, Safety and Tolerability of Topical CyclASol for Treatment of Dry Eye Disease
Phase of Trial: Phase II
Latest Information Update: 09 Nov 2017
At a glance
- Drugs Ciclosporin (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- Sponsors Novaliq
- 09 Nov 2017 According to a Novaliq media release, data will be presented at AAO 2017, the American Academy of Ophthalmologys 121st annual meeting.
- 28 Mar 2017 Status changed from active, no longer recruiting to completed.
- 05 Jan 2017 Top-line results published in a Novaliq media release.